Results 211 to 220 of about 27,407 (265)

Associations of finerenone with reduced insulin resistance in patients with type 2 diabetes and chronic kidney disease: A real‐world observational study

Journal of Diabetes Investigation, EarlyView.
This real‐world observational study enrolled 256 patients with type 2 diabetes and chronic kidney disease (T2D‐CKD). After 12 months of finerenone treatment, 45 patients completed follow‐up. Finerenone was associated with significant improvements in insulin resistance markers (HOMA‐IR, TyG index), lipid profile (LDL‐C), glycemic control (HbA1c), and ...
Xin Zhao, Bohan Liu, Ran Sun, Yaxuan Shi, Ya Liu   +4 more
wiley   +1 more source

Erythrocytosis after SGLT2 inhibitor initiation and anticoagulated outcomes in atrial fibrillation: a real-world analysis with counterfactual modeling. [PDF]

Cardiovasc Diabetol
Qi Z, Liu J, Gu T, Wu N, Liu J, Zhao J, Tse G, Lip GYH, Chen KY, Liu T.   +9 more
europepmc   +1 more source

Developing a machine learning model to predict renal function decline within three years using one‐year longitudinal data in patients with type 2 diabetes

Journal of Diabetes Investigation, EarlyView.
We developed a machine learning model to predict renal function decline in patients with type 2 diabetes and preserved kidney function. Using one year of routine clinical data, the model forecasts eGFR decline over three years, enabling early identification of high‐risk patients and supporting timely, targeted therapeutic interventions.
Mari Kaneda, Shu Meguro, Kaiken Kimura, Youichiro Harada, Makoto Enomoto, Kaori Hayashi   +5 more
wiley   +1 more source

Associations of skeletal muscle mass and strength with arterial stiffness in type 2 diabetes

Journal of Diabetes Investigation, EarlyView.
Lower skeletal muscle mass and lower handgrip strength were associated with higher arterial stiffness in individuals with type 2 diabetes. Assessment of both parameters may provide complementary information regarding vascular risk. ABSTRACT Sarcopenia is prevalent in people with type 2 diabetes mellitus (T2DM) and may contribute to increased ...
Naoki Koike, Yoko Irie, Yuji Doi, Ryosuke Kemmotsu, Moe Kusushita, Yasuna Sakai, Tomonori Okita, Hiroyuki Sho, Ryoko Inui, Yukiko Tabuchi, Tetsuyuki Yasuda   +10 more
wiley   +1 more source

Euglycemic diabetic ketoacidosis with gastrointestinal dysfunction following lung surgery in a patient on SGLT2 inhibitor: a case report. [PDF]

AME Case Rep
Liu Y, Wen J, Cai W, Jin J, Hu M, Han H, Qiu X, Xue Z.   +7 more
europepmc   +1 more source

Early SGLT2 Inhibitor Therapy in Acute Coronary Syndrome: Mitigating Adverse Remodeling in High-Risk Phenotypes-A Real-World Study. [PDF]

Medicina (Kaunas)
Mateoc T, Suciu IM, Gaiță D, Minodora A, Popescu R, Vlad T, Flangea C, Muntean C, Vlad DC.   +8 more
europepmc   +1 more source

Sex-consistent outcomes in SGLT2 inhibitor-treated acute myocardial infarction patients: a real-world study. [PDF]

Eur J Med Res
Guo C, Dou JH, Guo FS, Zhao S, Wu RY, Hu YW, Liu S, Wei J.   +7 more
europepmc   +1 more source

Emphysematous Cystitis in an Immunocompetent Patient on an SGLT2 Inhibitor. [PDF]

Cureus
Nguyen KN, Bista DR.
europepmc   +1 more source

Baseline Chronic Obstructive Pulmonary Disease Identifies a High-Risk Cardiopulmonary Phenotype in Patients with Heart Failure Undergoing SGLT2 Inhibitor Therapy. [PDF]

Diagnostics (Basel)
Jurin I, Pavlov M, Viđak M, Doder F, Patrk A, Vidaković I, Piskač Živković N.   +6 more
europepmc   +1 more source